The pH Miracle for Heart Disease – Discover the Truth About Heart Disease, Congestive Heart Failure, Atherosclerosis, Cholesterol, Hypertension, Stroke and More!

Introduction

Heart Disease has many symptomologies including, Atherosclerosis, Coronary Artery Disease (CAD), Carotid Artery Disease (CAD), Peripheral Arterial Disease (PAD), Hypertension, Hypercholesterolemia, Congestive Heart Failure (CHF) and Death

According to my theory ALL of the symptoms or conditions of Heart Disease are ALL the result of an excess of dietary, environmental, respiratory and/or metabolic acid that have not been properly eliminated through the four channels of elimination.  The four channels of elimination include urination, defecation, respiration and perspiration.

When metabolic and/or dietary acidic waste is not eliminated through the four channels of elimination they are either solidified by the body with alkaline compounds or pushed out into the connective and fatty tissues away from the organs and glands that sustain life.

Acidic metabolic and dietary waste when not eliminated from the blood or lymph fluid  is solidified and buffered with alkaline compounds such as sodium, potassium, calcium and/or LDL cholesterol forming plaque or acid crystals that build up on the inside of the arteries, veins and lymphatic vessels.  Plaque is made up of alkalizing fats, cholesterol, calcium, sodium bicarbonate, potassium and other alkaline substances found in the blood and interstitial fluids.  Over time, acid bound plaque hardens or crystallizes forming a solid mass and narrows the arteries, veins and lymphatic vessels as seen in this picture.  The flow of oxygen-rich blood and alkalizing compounds to the tissues, organs and glands that sustain life  is reduced due to the narrowing of the blood and lymph vessels.  The restriction of blood and lymph circulation and the build-up of metabolic and/or dietary acids can then lead to tissue, organ and gland ulceration and/or degeneration causing a stroke or heart attack leading to heart failure and sudden death.

 

Name(required)

Email(required)

Website

Comment(required)

Submit

Δ

Heart Disease is  Epidemic – Something Has Really Gone Wrong!

Today over 25% of the US population takes expensive and highly acidic statin medications and despite the fact we have reduced the fat content of our diets, more Americans will die this year of heart disease than ever before caused by acidic drugs and acidic lifestyles.

Statistics from the American Heart Association show that 75 million Americans currently suffer from heart disease, 20 million have diabetes and 57 million have pre-diabetes. These disorders are affecting younger and younger people in greater numbers every year.

No health topic is more important, more full of misinformation, and more complex than understanding the cause and effect relationship between inflammation and cardiovascular disease. This article tackles the four most common conditions associated with inflammation and  “heart disease”, including all of its symptomologies: hypertension, stroke, coronary heart disease, and congestive heart failure.  I believe the information herein will be life changing and life saving for all heart dis-ease problems.

 

Cardiovascular or heart disease is the number one killer in the United States, and yet it does not induce terror or fear as cancer does. The reason for this is because people are horrified of the acidic cancer treatments or chemotherapy, radiation and surgery and NOT the disease itself.  Alas, heart health is frequently ignored in lieu of cancer concerns, with breast cancer being an excellent example of this short sightedness. Case in point: For every woman who dies of breast cancer or from the cancer treatments (70 percent or higher) 11 more will die from coronary heart disease. About 60% of heart disease deaths happen suddenly in people who had no previous symptoms and normal LDL cholesterol levels. These people simply collapse unexpectedly. The real lesson here is to be educated, as you will see.  Everything that we have been taught about cardiovascular/heart disease is WRONG!  That’s right EVERYTHING!  If the so-called experts whom many of us have been listening to were right, than cardiovascular/heart disease would not be the #1 failure of modern-day medicine.

Adhering to a critical holistic principle of non-invasive alternative medicine or true health care, it is important that we never adopt the foolishness of a typical physician, who will obsessively focus on only the organ displaying obvious symptoms. It is wiser to treat the whole patient instead of an organ, which means correcting problems with both lifestyle and diet. As is the case for practically all other chronic dis-eases! A heart patient usually brings the dis-ease upon himself or herself with his or irresponsible acidic lifestyle behavior for a period of many years, and only he/she can get himself/herself out of this acidic mess. Acidic toxic drugs can suppress symptoms for a while, like they do, but real change comes only from real changes in what you eat, what you drink and what you think.  Merely masking the symptoms with toxic acidic drugs is the health policy of fools. The time bomb for a heat attack or stroke is still ticking, even though the timer has been hidden from view with useless modern-day big Pharma drugs.

Portable Ultrasound to Detect Potential Heart Attacks and Stroke

Recent research reveals that portable ultrasound can reveal plaques in peripheral arteries that may lead to heart attacks and strokes before symptoms arise, in both developed and developing country settings

A study of portable ultrasound carried out in the US, Canada and India has revealed the potential of this technology for detecting plaques in peripheral arteries that can lead to heart attacks and stroke before symptoms arise, in both developed and developing country settings, allowing preventive treatment in those affected. The study, published in Global Heart (the journal of the World Heart Federation), is by Dr Ram Bedi, Affiliate Assistant Professor, Department of Bioengineering, University of Washington, Seattle, WA, US, and Professor Jagat Narula, Editor-in-Chief of Global Heart and Icahn School of Medicine at Mount Sinai, New York, US, and colleagues.

Numerous studies have shown that it is possible to assess subclinical atherosclerotic cardiovascular disease (ASCVD) using ultrasound imaging. Since more portable and lower cost ultrasound devices are now entering the market, along with increased automation and functionality, it may be possible in future to routinely examine people with ultrasound to establish any ASCVD present before symptoms emerge, so that future disease can be prevented, for e.g. using medication. In this study, ASCVD was determined using ultrasound of both the carotid arteries (those in the neck) and the ileofemoral arteries (entering the top of the leg). The findings were summarised in an index called the Fuster-Narula (FUN) Score.

Data were gathered from four cohorts, two Indian and two North American. In India, screening with automated ultrasound imaging was conducted over eight days in 941 relatively young (mean age 44 years, 34 per cent female) asymptomatic volunteers recruited from the semiurban town of Sirsa (Haryana) and urban city of Jaipur (Rajasthan) in northern India. The cohort from Sirsa was recruited because all participants had already undergone aggressive lifestyle changes (smoking cessation, no alcohol, vegetarian diet, physically active lifestyles, daily meditation).

To compare the imaging findings with traditional risk factors, two cohorts (481 persons) were recruited from primary care clinics in North America (one in Richmond, Texas, US, the other in Toronto, Canada). Apart from the same ultrasound examinations given in the Indian cohort, comprehensive ASCVD risk factor data was gathered from the participants. All of them were self-referred asymptomatic individuals (mean age 60 years, 39 per cent female). Data collected included cholesterol levels, blood pressure, glucose level, weight, height, smoking and family history. These people were attending clinics for routine health check-ups in most cases. Effectiveness of established ASCVD prevention guidelines was then compared to results from direct imaging.

In India, ultrasound revealed plaques in at least one artery in almost a quarter (24 per cent) of those examined; 107 (11 per cent) had plaques in only the carotids, 70 (seven per cent) in both the carotids and iliofemoral arteries, and 47 (five per cent) had plaques in only the iliofemoral arteries. If just the carotids had been examined, 177 (19 per cent) of the asymptomatic subjects would have been identified with plaques; by adding the iliofemoral examination, 47 additional individuals (five per cent of the total) were identified with plaque. Older age and male sex were associated with the presence of plaque both in urban and semiurban populations (the much higher levels of smoking in men could account for their higher risk).

Data from the American and Canadian clinics showed that 203 subjects (42 per cent) had carotid plaque; 166 of these (82 per cent of those with plaque) would not have qualified for lipid-lowering therapy such as statins under widely used guidelines known as ATP III (Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [Adult Treatment Panel]) guidelines. Using the recently published more stringent ATP IV guidelines, 67 people (one third of those with plaque and 14 per cent of the total US/Canadian cohort) individuals with carotid plaque would also have failed to qualify for treatment.

In addition, the study revealed 34 people in the US/ Canada setting who qualified for treatment under ATP III but did not have any plaques, and this number increased to 81 under ATP IV (if receiving treatment such as statins, these people could be said to be overtreated, since no plaques were evident).

The authors say, “Our study shows that automation in ultrasound imaging technology allows even non-expert users to rapidly evaluate the presence of subclinical atherosclerosis in a large population. Detection of sub-clinical atherosclerosis is further enhanced by inclusion of the iliofemoral artery examination.” They add, “It seems that plaque information from ultrasound images may serve as a guide for initiating medical intervention regardless of the availability or knowledge of traditional risk factors. Our results further suggest that not only in low- and middle-income countries, but even in the developed nations, ultrasound images may help refine strategies for medical intervention. It might however still be too contentious to suggest that risk factors–positive and imaging-negative asymptomatic subjects may be spared from medical intervention. Conversely, arguments against initiating medical intervention on risk factors–negative and imaging-positive asymptomatic subjects become harder to justify.”

In a linked comment, Dr Tasneem Z Naqvi, Professor of Medicine , Mayo College of Medicine and Division of Cardiology, Scottsdale, Arizona, US, adds, “This study shows that the assessment of subclinical atherosclerosis by a portable, user-friendly bedside tool is feasible in large populations and the technique of carotid ultrasound imaging and IMT assessment could be adopted by novices after an eight-hour crash course.” She concludes that the study shows that vascular ultrasound imaging technology is ripe and the previously existing barriers like poor resolution, cumbersome protocols, need for off line processing and need for expert performer no longer exist. However, she says that the study does not address whether this imaging-based approach would save more lives than the risk-based approach. “We need to ponder if treating nearly 50 per cent of the adults with statins with a risk scoring algorithm is more appropriate versus treating only those who have subclinical atherosclerosis based on comprehensive and readily available, cheap and simple screening method,” she says. The study makes a compelling argument in favour of imaging for screening, she states.